7Baggers
 Mersana Therapeutics to be Acquired by Day One  TipRanks Sat, 15 Nov 2025 03:59:32 GMT
 mersana therapeutics earnings missed by $1.37, revenue topped estimates  ng.investing.com Sat, 15 Nov 2025 00:59:47 GMT
 Mersana Therapeutics reports Q3 EPS ($1.51), consensus (89c)  TipRanks Fri, 14 Nov 2025 16:18:40 GMT
 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of  GlobeNewswire Fri, 14 Nov 2025 15:42:09 GMT
 MRSN: Guggenheim Downgrades Mersana Therapeutics to Neutral | MR  GuruFocus Fri, 14 Nov 2025 15:06:33 GMT
 Day One to buy cut-price Mersana in deal worth $285 million  The Pharma Letter Fri, 14 Nov 2025 14:04:09 GMT
 Mersana Therapeutics, Inc. SEC 10-Q Report  TradingView Fri, 14 Nov 2025 13:13:01 GMT
 mrsn misses q3 revenue estimates amid solid cash position  GuruFocus Fri, 14 Nov 2025 12:52:07 GMT
 Mersana Therapeutics Q3 loss widens  MarketScreener Fri, 14 Nov 2025 12:21:16 GMT
 Day One to acquire Mersana Therapeutics for up to $285 million By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 03:04:48 GMT
 heatmap analysis for mersana therapeutics inc. and competitors  newser.com Fri, 14 Nov 2025 00:27:37 GMT
 Mersana Therapeutics downgraded to Neutral from Buy at BTIG  TipRanks Thu, 13 Nov 2025 23:56:13 GMT
 Fenwick, WilmerHale Steer $285M Mersana Take-Private Deal  Law360 Thu, 13 Nov 2025 22:52:00 GMT
 Biotech Stock Catapults 200% On Surprise Takeover  Investor's Business Daily Thu, 13 Nov 2025 21:31:00 GMT
 mrsn downgraded by truist securities: price target lowered to $3  GuruFocus Thu, 13 Nov 2025 19:08:58 GMT
 Day One snaps up ADC maker Mersana in backloaded buyout deal  BioPharma Dive Thu, 13 Nov 2025 17:07:39 GMT
 Guggenheim Downgrades Mersana Therapeutics to Neutral From Buy  MarketScreener Thu, 13 Nov 2025 17:04:19 GMT
 Mersana Therapeutics downgraded to Hold from Buy at Truist  TipRanks Thu, 13 Nov 2025 16:06:26 GMT
 Mersana Therapeutics Earnings Preview  Benzinga Thu, 13 Nov 2025 16:02:52 GMT
 Day One pens $285M deal for Mersana and its clinical-stage B7-H4 ADC  Fierce Biotech Thu, 13 Nov 2025 15:15:00 GMT
 Mersana soars on Day One's $285 mln buyout deal  TradingView Thu, 13 Nov 2025 15:00:35 GMT
 mersana catapults 200% on day one bio's surprise buyout  MSN Thu, 13 Nov 2025 14:23:09 GMT
 mrsn stock soars 201% after acquisition by day one biopharma  GuruFocus Thu, 13 Nov 2025 14:14:21 GMT
 Once a billion-dollar ADC darling, Mersana finds a buyer in Day One  FirstWord Pharma Thu, 13 Nov 2025 13:31:33 GMT
 Why Is Mersana Therapeutics Stock (MRSN) Up Today?  TipRanks Thu, 13 Nov 2025 12:46:12 GMT
 Day One Biopharma Bets Big On Mersana Therapeutics Buyout  Finimize Thu, 13 Nov 2025 12:20:28 GMT
 day one biopharmaceuticals announces mersana acquisition deal  TipRanks Thu, 13 Nov 2025 12:20:19 GMT
 Mersana Therapeutics stock soars 200% after Day One acquisition offer  Investing.com Thu, 13 Nov 2025 12:08:31 GMT
 Mersana Therapeutics Announces Merger with Day One  TipRanks Thu, 13 Nov 2025 11:50:34 GMT
 Day One to acquire Mersana Therapeutics for up to $285 million By Investing.com  Investing.com Australia Thu, 13 Nov 2025 11:47:05 GMT
 day one biopharmaceuticals : acquisition of mersana therapeutics  MarketScreener Thu, 13 Nov 2025 11:16:11 GMT
 day one to acquire mersana therapeutics in deal worth up to $285 million  Investing.com India Thu, 13 Nov 2025 11:16:11 GMT
 Day One Biopharmaceuticals to Acquire Mersana Therapeutics  Yahoo Finance Thu, 13 Nov 2025 11:00:00 GMT
 day one to acquire mersana therapeutics to advance mission  GlobeNewswire Thu, 13 Nov 2025 11:00:00 GMT
 mersana therapeutics announces merger with day one  MSN Wed, 12 Nov 2025 08:00:00 GMT
 mersana therapeutics shares face pressure ahead of earnings report  AD HOC NEWS Sat, 08 Nov 2025 15:02:04 GMT

Mersana Therapeutics, Inc
(NASDAQ:MRSN) 

MRSN stock logo

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development of antibody drug conjugates (ADC) for cancer patients with unmet need. The company develops XMT-1536, a Dolaflexin ADC targeting NaPi2b that is in Phase I clinical trial for the treatment of patients w...

Founded: 2001
Full Time Employees: 83
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends